Gabapentin Tablet
Product Images NDC 71205-932

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-932). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapentin 01)

Chemical structure of Gabapentin, showing the cyclohexane ring with amino and carboxyl functional groups attached, corresponding to the active ingredient Gabapentin.*

FDA Label Image

Figure 1 (Gabapentin 02)

A line graph comparing mean pain scores over an 8-week period between placebo and Gabapentin at 3600 mg/day. The horizontal axis represents weeks from baseline through week 8, and the vertical axis represents mean pain scores from 0 to 10. The graph indicates a 4-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 2 (Gabapentin 03)

A line graph showing mean pain score over weeks comparing placebo and gabapentin doses of 1800 mg/day and 2400 mg/day. The x-axis represents time in weeks from baseline through week 7, divided into a 3-week dose titration and a 4-week fixed dose period. The y-axis displays mean pain score values from 0 to 10. Gabapentin doses show a decreasing trend in mean pain score compared to placebo over time.*

FDA Label Image

Figure 3 (Gabapentin 04)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares response rates between placebo (PBO) and Gabapentin (GBP) at different doses across two studies. Study 1 shows 12% response for placebo and 29% for GBP 3600 mg. Study 2 shows 14% response for placebo and 32% and 34% for GBP 1800 mg and 2400 mg, respectively, with significance levels marked for statistical comparisons.*

FDA Label Image

Figure 4 (Gabapentin 05)

A scatter plot chart showing the percent difference on the vertical axis against daily dose in mg on the horizontal axis. Data points represent three studies labeled as Study A (black squares), Study B (white squares), and Study C (white circles) across various daily doses ranging from 600 mg to 1800 mg. The chart visually compares the difference percentages at these doses among the three studies.*

FDA Label Image

71205-931-30 (Image 01)

Label for Gabapentin 600 mg tablets, oral dosage form, available as a quantity of 30 tablets. The label shows it is prescription only (RX Only) and includes detailed tablet description as white to off-white, biconvex, film-coated tablets with specific embossing. Packaged by Proficient Rx LP, with manufacturer ScieGen Pharmaceuticals, Inc. Storage instructions are noted as 20°-25°C (68°-77°F).*

FDA Label Image

71205-932-30 (Image 02)

Label for Gabapentin 800 mg tablets from Proficient Rx. The label states 240 tablets/package, film-coated, biconvex tablets with markings "SG" and "178." Manufactured by ScieGen Pharmaceuticals, Inc. The label includes storage instructions and dispensing guidelines, noting the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.